Adm. Lisa Franchetti, the Navy’s top admiral, announced Friday, Sept. 20, 2024, that she is cancer free after recently undergoing several weeks of breast cancer treatment. (Stars and Stripes)

Adm. Lisa Franchetti, the Navy’s top admiral, is cancer free after recently undergoing several weeks of breast cancer treatment, her office announced Friday.

Franchetti, the chief of naval operations, was diagnosed with Stage 1 breast cancer in June during a routine mammogram, according to Cmdr. Desiree Frame, spokeswoman for the admiral.

Franchetti underwent outpatient surgery in July, which Frame said was successful. During the surgery, her authority was temporarily transported to Adm. James Kilby, the vice chief of naval operations.

Franchetti has since completed radiation therapy. In September, she began maintenance endocrine therapy, which is used to prevent or delay relapse.

“I am grateful for my wonderful team of doctors at John P. Murtha Cancer Center for their excellent care and their development of a treatment plan that allows me to continue leading the world’s greatest Navy,” Franchetti said in a prepared statement. “I am blessed that this was detected early and will forever be an advocate for early and routine screening.”

Franchetti is serving as the Navy’s 33rd chief of naval operations, a position she has held since Nov. 2, 2023. She is the first woman to serve in the role.